Superiority of tc-99m MAG3 to tc-99m DTPA in treating a patient with mild renal artery stenosis.
A 22-year-old female patient with severe hypertension underwent both Technetium-99m diethylenetriaminepentaacetate and Technetium-99m mercaptoacetyltriglycine basal and captopril renal scintigraphy. While no significant change was seen with Tc-99m DTPA, there was left sided parenchymal retention of captopril Tc-99m MAG3 suggesting renal artery stenosis which was confirmed by angiography.
Kiratli
P O
PO
Department of Nuclear Medicine, Hacettepe University Medical Centre, Ankara, Turkey. pinar_kiratli@hotmail.com
Caner
B
B
Altun
B
B
Cekirge
S
S
D000328:Adult; D000792:Angiography; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril; D005260:Female; D006801:Humans; D006978:Hypertension, Renovascular / Q000209:etiology; D007668:Kidney / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D012078:Renal Artery Obstruction / Q000000981:diagnostic imaging*; D017263:Technetium Tc 99m Mertiatide / Q000493:pharmacokinetics; D016284:Technetium Tc 99m Pentetate / Q000493:pharmacokinetics; D014018:Tissue Distribution
D019275:Radiopharmaceuticals; D017263:Technetium Tc 99m Mertiatide; D002216:Captopril; D016284:Technetium Tc 99m Pentetate